Photo of Saranya Chumsri

View Scopus Profile

Saranya Chumsri, MD

  • 1815 Citations
  • 22 Scopus h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Saranya Chumsri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
letrozole Medicine & Life Sciences
exemestane Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

1 Citation (Scopus)

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journal › Article

Randomized Controlled Trials
Hormones
Breast Neoplasms
Disease-Free Survival
Neoplasms

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journal › Article

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab
2 Citations (Scopus)

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Moreno Aspitia, A., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journal › Article

Disease-Free Survival
Breast Neoplasms
Research Design
Therapeutics
Biomarkers
111 Citations (Scopus)

Next generation of immune checkpoint therapy in cancer: New developments and challenges

Marin-Acevedo, J. A., Dholaria, B., Soyano, A. E., Knutson, K. L., Chumsri, S. & Lou, Y., Mar 15 2018, In : Journal of Hematology and Oncology. 11, 1, 39.

Research output: Contribution to journal › Review article

CD274 Antigen
Neoplasms
Cytotoxic T-Lymphocytes
Programmed Cell Death 1 Receptor
Therapeutics
10 Citations (Scopus)

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Soyano, A. E., Dholaria, B., Marin-Acevedo, J. A., Diehl, N., Hodge, D., Luo, Y., Manochakian, R., Chumsri, S., Adjei, A., Knutson, K. L. & Lou, Y., Nov 23 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 129.

Research output: Contribution to journal › Article

Non-Small Cell Lung Carcinoma
Cell Death
Lymphocyte Count
Biomarkers
Neutrophils